Hernandez L, Toro-Diaz H, Cele C, et al. Dimethyl Fumarate demonstrates Costeffectiveness vs Teriflunomide in Treatment-naïve Patients with Relapsingremitting Multiple Sclerosis in Sweden. EAN 2018; poster EPO1092.
Goede resultaten van evobrutinib in fase II-studie
okt 2018 | Multipele Sclerose